Skip to content

Upstream Bio, Inc. UPB Interest Income

Interest Income at other companies

Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$1.51M-30.1%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$779K+13.1%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$2.65M-39.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$4.1M-37.7%
Septerna, Inc. logo
Septerna, Inc.SEPN
$5.03M+12.8%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$8.74M+11.5%

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s interest income?
Upstream Bio, Inc. (UPB) reported interest income of $3.05M in Q1 2026.
How has Upstream Bio, Inc.'s interest income changed year-over-year?
Upstream Bio, Inc.'s interest income decreased by 35.6% year-over-year, from $4.74M to $3.05M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.